TD
Translational Development Acquisition Corp. Units (TDACU)
NASDAQ·Technology·General
$12.57
—
Mkt Cap $246.12M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$251.85
Range $170.82 – $295.65
Implied Upside
+1903.6%
Consensus $251.85 vs current $12.57